Susquehanna International Group
KRON

Susquehanna International Group’s Kronos Bio KRON Stock Holding History

Susquehanna International Group’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,600
Closed -$27K – 12793
2023
Q4 		$27K Buy
21,600
+1,400
+7% +$1.55K ﹤0.01% 11904
2023
Q3 		$26.3K Buy
+20,200
New +$32.6K ﹤0.01% 11528
2023
Q1 		– Sell
-12,400
Closed -$20.1K – 13077
2022
Q4 		$20.1K Buy
+12,400
New +$28.5K ﹤0.01% 11762
2022
Q3 		– Sell
-94,700
Closed -$345K – 13694
2022
Q2 		$345K Buy
94,700
+6,100
+7% +$27.6K ﹤0.01% 9194
2022
Q1 		$641K Buy
+88,600
New +$755K ﹤0.01% 8286

Susquehanna International Group's KRON Position: Q2 2025 in Review

Susquehanna International Group sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 155,188 shares — an estimated $128K sold.

Susquehanna International Group first reported a position in KRON in Q4 2021 and held it in 12 quarters. The position peaked at $409K in Q4 2021. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Susquehanna International Group reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 155,188 Kronos Bio shares in Q2 2025, an estimated $128K.
  • Susquehanna International Group first reported a position in Kronos Bio in Q4 2021 and held it in 12 quarters.
  • Susquehanna International Group's Kronos Bio position peaked at $409K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.